700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Commentary Open Access
In 2010 in Italy, there were 175,046 cancer deaths, with total mortality rates, respectively for men and women, of 138 and 83/100,000 . Total cancer mortality in Italy has been declining since the 1980s in men and earlier in women , similarly to most European countries  and the United States . However, some rising trends have also been observed, notably for female lung cancer and pancreatic cancer in both sexes . Although the incidence of pancreatic cancer is relative low compared to other tumor types such as breast, lung and prostate cancer, in pancreatic cancer the mortality is almost equal to the incidence level, with 41,780 and 40,560 deaths predicted in Europe and USA respectively [2,4]. For this reason, PDA is the 4th leading cause of cancer deaths in the Western Countries [1,2,4]. Despite the efforts of clinicians and scientists, pancreatic cancer has the worst prognosis of all major malignancies, with a 5-year survival rate of 8% .
Pancreatic cancer, ENO1, Antibody, Immunotherapy, Pancreatic cancer, ENO1, Antibody, Immunotherapy